NCT02693158View on ClinicalTrials.gov

The Direct III Post Market Study

CompletedOBSERVATIONAL
Enrollment

440

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2020

Conditions
Coronary Artery Disease
Trial Locations (8)

Unknown

Meander Medical Center, Amersfoort

University Medical Center, Utrecht

1091 AC

OLVG, Amsterdam

1261AN

Tergooi Hospital, Blaricum

4819 EV

Amphia Ziekenhuis, Breda

3300 AK

Albert Schweitzer Hospital, Dordrecht

3430 EM

St Antonius Hospital, Nieuwegein

2545 AA

HagaZiekenhuis, The Hague

All Listed Sponsors
lead

Svelte Medical Systems, Inc.

INDUSTRY

NCT02693158 - The Direct III Post Market Study | Biotech Hunter | Biotech Hunter